Aromics selected at the program of EIT Health investor network

As part of the strategy to attract investment for the clinical development of its products for the treatment of cancer, Aromics has been selected to be part of the European Institute of Technology (EIT) Health Investors Network, which will support the company in navigating this fundraising process. The EIT Health Investors' Network facilitates early stage fundraising across Europe to help accelerate the arrival of innovative ideas in health markets more quickly. The network connects qualified companies seeking funding with a group of selected European investors. The network works with investors, including early stage venture capital funds, family offices, business angel or superangels networks.